These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
499 related items for PubMed ID: 11379810
1. A randomized, double-blind comparison of beclomethasone dipropionate extrafine aerosol and fluticasone propionate. Fairfax A, Hall I, Spelman R. Ann Allergy Asthma Immunol; 2001 May; 86(5):575-82. PubMed ID: 11379810 [Abstract] [Full Text] [Related]
2. Beclometasone dipropionate extrafine aerosol versus fluticasone propionate in children with asthma. van Aalderen WM, Price D, De Baets FM, Price J. Respir Med; 2007 Jul; 101(7):1585-93. PubMed ID: 17254760 [Abstract] [Full Text] [Related]
3. A study on the clinical equivalence and patient preference of fluticasone propionate 250 microg twice daily via the Diskus/Accuhaler inhaler or the Diskhaler inhaler in adult asthmatic patients. Pieters WR, Stallaert RA, Prins J, Greefhorst AP, Bosman HG, van Uffelen R, Schreurs AJ, van Helmond JL, Janssen PG. J Asthma; 1998 Jul; 35(4):337-45. PubMed ID: 9669827 [Abstract] [Full Text] [Related]
4. Stepping-across controlled asthmatic patients to extrafine beclometasone/formoterol combination. Barnes N, van Noord JA, Brindicci C, Lindemann L, Varoli G, Perpiña M, Guastalla D, Casula D, Patel S, Chanez P, FACTO (Foster® As Complete Treatment Option) Study Group. Pulm Pharmacol Ther; 2013 Oct; 26(5):555-61. PubMed ID: 23524015 [Abstract] [Full Text] [Related]
5. Extrafine beclomethasone dipropionate breath-actuated inhaler (400 micrograms/day) versus budesonide dry powder inhaler (800 micrograms/day) in asthma. Reichel W, Dahl R, Ringdal N, Zetterstrom O, van den Elshout FJ, Laitinen LA. Int J Clin Pract; 2001 Mar; 55(2):100-6. PubMed ID: 11321849 [Abstract] [Full Text] [Related]
6. Safety and efficacy of fluticasone and beclomethasone in moderate to severe asthma. Belgian Multicenter Study Group. Pauwels RA, Yernault JC, Demedts MG, Geusens P. Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):827-32. PubMed ID: 9517598 [Abstract] [Full Text] [Related]
7. Comparative clinical study of inhaled beclomethasone dipropionate and triamcinolone acetonide in persistent asthma. Bronsky E, Korenblat P, Harris AG, Chen R. Ann Allergy Asthma Immunol; 1998 Apr; 80(4):295-302. PubMed ID: 9564977 [Abstract] [Full Text] [Related]
8. Long-term safety and efficacy of a chlorofluorocarbon-free beclomethasone dipropionate extrafine aerosol. Fireman P, Prenner BM, Vincken W, Demedts M, Mol SJ, Cohen RM. Ann Allergy Asthma Immunol; 2001 May; 86(5):557-65. PubMed ID: 11379808 [Abstract] [Full Text] [Related]
9. Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma. Pearlman DS, Stricker W, Weinstein S, Gross G, Chervinsky P, Woodring A, Prillaman B, Shah T. Ann Allergy Asthma Immunol; 1999 Mar; 82(3):257-65. PubMed ID: 10094216 [Abstract] [Full Text] [Related]
10. Efficacy of HFA-beclomethasone dipropionate extra-fine aerosol (800 microg day(-1)) versus HFA-fluticasone propionate (1000 microg day(-1)) in patients with asthma. Aubier M, Wettenger R, Gans SJ. Respir Med; 2001 Mar; 95(3):212-20. PubMed ID: 11266239 [Abstract] [Full Text] [Related]
11. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study. Maspero J, Guerra F, Cuevas F, Gutierrez JP, Soto-Ramos M, Anderton S, Mechali D, Chan R, Pedersen S. Clin Ther; 2008 Aug; 30(8):1492-504. PubMed ID: 18803991 [Abstract] [Full Text] [Related]
12. Diskus and diskhaler: efficacy and safety of fluticasone propionate via two dry powder inhalers in subjects with mild-to-moderate persistent asthma. Galant SP, van Bavel J, Finn A, Gross G, Pleskow W, Brown A, Hamedani AG, Harding SM. Ann Allergy Asthma Immunol; 1999 Mar; 82(3):273-80. PubMed ID: 10094218 [Abstract] [Full Text] [Related]
13. Extrafine beclomethasone/formoterol combination via a dry powder inhaler (NEXThaler(®)) or pMDI and beclomethasone monotherapy for maintenance of asthma control in adult patients: A randomised, double-blind trial. Kanniess F, Scuri M, Vezzoli S, Francisco C, Petruzzelli S. Pulm Pharmacol Ther; 2015 Feb; 30():121-7. PubMed ID: 25088067 [Abstract] [Full Text] [Related]
14. Initiation of maintenance therapy with salmeterol/fluticasone propionate combination therapy in moderate asthma: a comparison with fluticasone propionate. Rojas RA, Paluga I, Goldfrad CH, Duggan MT, Barnes N. J Asthma; 2007 Feb; 44(6):437-41. PubMed ID: 17654129 [Abstract] [Full Text] [Related]
15. A comparison of fluticasone propionate, 1 mg daily, with beclomethasone dipropionate, 2 mg daily, in the treatment of severe asthma. International Study Group. Barnes NC, Marone G, Di Maria GU, Visser S, Utama I, Payne SL. Eur Respir J; 1993 Jun; 6(6):877-85. PubMed ID: 8339809 [Abstract] [Full Text] [Related]
16. A six-month, placebo-controlled comparison of the safety and efficacy of salmeterol or beclomethasone for persistent asthma. Nathan RA, Pinnas JL, Schwartz HJ, Grossman J, Yancey SW, Emmett AH, Rickard KA. Ann Allergy Asthma Immunol; 1999 Jun; 82(6):521-9. PubMed ID: 10400478 [Abstract] [Full Text] [Related]
17. Pharmacokinetics of beclomethasone 17-monopropionate from a beclomethasone dipropionate extrafine aerosol in adults with asthma. Harrison LI, Kurup S, Wagner C, Ekholm BP, Larson JS, Kaiser HB. Eur J Clin Pharmacol; 2002 Jun; 58(3):197-201. PubMed ID: 12107606 [Abstract] [Full Text] [Related]
18. Fluticasone propionate does not influence bone metabolism in contrast to beclomethasone dipropionate. Bootsma GP, Dekhuijzen PN, Festen J, Mulder PG, Swinkels LM, van Herwaarden CL. Am J Respir Crit Care Med; 1996 Mar; 153(3):924-30. PubMed ID: 8630574 [Abstract] [Full Text] [Related]
19. [Effect of fluticasone propionate at half dose of beclomethasone dipropionate divided twice daily and once daily in asthmatics inhaling beclomethasone dipropionate 800 micrograms daily or more]. Hasegawa T, Tomii K, Kikumoto N, Sakamoto H, Maekawa T, Katayama S, Kamei T, Sakamoto Y, Fujii H, Ishihara K. Arerugi; 2001 Apr; 50(4):379-84. PubMed ID: 11398334 [Abstract] [Full Text] [Related]
20. Dose-ranging study of mometasone furoate dry powder inhaler in the treatment of moderate persistent asthma using fluticasone propionate as an active comparator. O'Connor B, Bonnaud G, Haahtela T, Luna JM, Querfurt H, Wegener T, Lutsky BN. Ann Allergy Asthma Immunol; 2001 Apr; 86(4):397-404. PubMed ID: 11345282 [Abstract] [Full Text] [Related] Page: [Next] [New Search]